Serum Soluble Programmed Death Ligand 1 is Correlated with HBsAg Level and Nucleos(t)ide Analogue Therapy in Chronic Hepatitis B
1. Abstract 1.1. Aims: Restoration of immune responses is considered as a com- plementary approach to Nucleos(t)ide analogue (NUC) therapy for chronic Hepatitis B Virus (HBV) infection. Antiviral immunity is negatively regulated by the Programmed cell Death-1 (PD-1)/Pro- grammed Death Ligand 1 (PD-L1) axis. In the present study, soluble PD-L1 (sPD-L1), which represents the amount …